Intelligence for Metabolic Specialists

Active Clinical Trials in
Metabolic Disease in Brazil

Up-to-date overview of clinical trials in obesity, type 2 diabetes and other metabolic conditions recruiting patients in Brazil — automatically compiled from ClinicalTrials.gov. Refer eligible patients to participating research centres.

41
Active trials
199
Sites in Brazil
16
Indications covered
Carregando mapa…

41 studies found

N/DDiabetes Mellitus Tipo 2HipertensãoDoença Renal Crônica🇧🇷 14 sites in Brazil

iCaReMe Global Registry

AstraZeneca

📍 Fortaleza, Colatina, Salvador, Brasília, Poços de Caldas, Campina Grande do Sul, Teresina, Santa Cruz do Sul, Goiânia, Joinville, Bragança Paulist, São Caetano do Sul, São Paulo👥 35000 participants📅 Completion: 2025-12
View details →Refer patient →ClinicalTrials.gov ↗
N/DSobrepeso e Obesidade🇧🇷 2 sites in Brazil

Chronic Effect of Fasting

Federal University of Minas Gerais

📍 Belo Horizonte👥 45 participants📅 Completion: 2026-12
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Diabetes Tipo 2 com Dislipidemia🇧🇷 1 site in Brazil

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

EMS

📍 Campinas👥 228 participants📅 Completion: 2027-09
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Diabetes Mellitus Tipo 2🇧🇷 1 site in Brazil

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

EMS

📍 Hortolândia👥 270 participants📅 Completion: 2027-06
View details →Refer patient →ClinicalTrials.gov ↗
Fase 2Diabetes Mellitus Tipo 2🇧🇷 1 site in Brazil

Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes

Hospital de Clinicas de Porto Alegre

📍 Porto Alegre👥 94 participants📅 Completion: 2025-12
View details →Refer patient →ClinicalTrials.gov ↗
N/DDiabetes Mellitus Tipo 2Doenças CardiovascularesDoença Arterial Coronariana🇧🇷 1 site in Brazil

Brazilian Diabetes Study: a Type 2 Diabetes Prospective Cohort

University of Campinas, Brazil

📍 Campinas👥 1046 participants📅 Completion: 2026-05
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Diabetes Mellitus Tipo 2🇧🇷 1 site in Brazil

Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus

EMS

📍 Hortolândia👥 480 participants📅 Completion: 2027-09
View details →Refer patient →ClinicalTrials.gov ↗
N/DDiabetes Mellitus Tipo 2🇧🇷 2 sites in Brazil

Effect of Nutrition Education Groups in the Treatment of Patients with Type 2 Diabetes

Hospital de Clinicas de Porto Alegre

📍 Porto Alegre👥 252 participants📅 Completion: 2025-10
View details →Refer patient →ClinicalTrials.gov ↗
N/DDiabetes Mellitus Tipo 2Sobrepeso e Obesidade🇧🇷 1 site in Brazil

Effect of Partial Dietary Replacement From Animal to Plant-Based Protein for Type 2 Diabetes Management

Hospital de Clinicas de Porto Alegre

📍 Porto Alegre👥 146 participants📅 Completion: 2027-12
View details →Refer patient →ClinicalTrials.gov ↗
Fase 2, Fase 3Dor Crônica de JoelhoObesidade Mórbida🇧🇷 1 site in Brazil

Photobiomodulation in Chronic Knee Pain in Patients Who Are in PreRehabilitation for Bariatric Surgery

University of Nove de Julho

📍 Goiânia👥 62 participants📅 Completion: 2026-02
View details →Refer patient →ClinicalTrials.gov ↗
N/DObesidade🇧🇷 1 site in Brazil

Laparoscopic Ileal Interposition and Weight Regain

Rio de Janeiro State University

📍 Rio de Janeiro👥 30 participants📅 Completion: 2026-05
View details →Refer patient →ClinicalTrials.gov ↗
N/DObesidadeVariabilidade da Frequência CardíacaTranstornos de Ansiedade🇧🇷 1 site in Brazil

Obesity and Bariatric Surgery According to a Biopsychosocial Perspective.

Rio de Janeiro State University

📍 Rio de Janeiro👥 50 participants📅 Completion: 2026-10
View details →Refer patient →ClinicalTrials.gov ↗
N/DPeriodontiteObesidade🇧🇷 1 site in Brazil

Effects of Adjunct Antimicrobial Photodynamic Therapy in Periodontal Treatment of Patients with Obesity

University of Sao Paulo

📍 Bauru👥 24 participants📅 Completion: 2025-06
View details →Refer patient →ClinicalTrials.gov ↗
N/DPré-diabetes🇧🇷 2 sites in Brazil

Effectiveness of the Brazilian Diabetes Prevention Program

Beneficência Portuguesa de São Paulo

📍 Goiânia, Viçosa👥 1590 participants📅 Completion: 2029-12
View details →Refer patient →ClinicalTrials.gov ↗
N/DDiabetes Mellitus Tipo 2Síndrome de Fragilidade do Idoso🇧🇷 1 site in Brazil

The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM

Hospital de Clinicas de Porto Alegre

📍 Porto Alegre👥 220 participants📅 Completion: 2028-12
View details →Refer patient →ClinicalTrials.gov ↗
N/DMenopausaSobrepesoObesidade🇧🇷 1 site in Brazil

Effects of SlimTrack® Platform on Diet Adherence, Anthropometry and Arterial Stiffness in Postmenopausal Women

Instituto de Cardiologia do Rio Grande do Sul

📍 Porto Alegre👥 64 participants📅 Completion: 2025-11
View details →Refer patient →ClinicalTrials.gov ↗
N/DObesidade🇧🇷 1 site in Brazil

Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adult Patients With Obesity.

University of Roma La Sapienza

📍 Pelotas👥 400 participants📅 Completion: 2025-12
View details →Refer patient →ClinicalTrials.gov ↗
N/DObesidade🇧🇷 2 sites in Brazil

Effects of High-intensity Exercise With Hypoxia and Taurine Supplementation on Metabolic and Mitochondrial Parameters

University of Sao Paulo

📍 Ribeirão Preto👥 50 participants📅 Completion: 2025-12
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3ObesidadeSobrepeso🇧🇷 3 sites in Brazil

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Eli Lilly and Company

📍 Brasília, Caxias do Sul, São Paulo👥 125 participants📅 Completion: 2027-03
View details →Refer patient →ClinicalTrials.gov ↗
N/DDiabetes Mellitus Tipo 2Obesidade🇧🇷 1 site in Brazil

Research on Effects of Acute Consumption of Nuts in Obese Diabetic Women

Raquel Ballarin

📍 Botucatu👥 15 participants📅 Completion: 2025-07
View details →Refer patient →ClinicalTrials.gov ↗
Fase 2Doença Renal Crônica🇧🇷 6 sites in Brazil

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Novo Nordisk A/S

📍 Curitiba, Porto Alegre, São Paulo👥 465 participants📅 Completion: 2026-09
View details →Refer patient →ClinicalTrials.gov ↗
N/DDiabetes Mellitus Tipo 2HipertensãoObesidade🇧🇷 1 site in Brazil

Eating Window and Sleep Disorders on Glycemic Control, Cardiovascular Risk, and Weight Loss

Federal University of São Paulo

📍 Santos👥 32 participants📅 Completion: 2027-10
View details →Refer patient →ClinicalTrials.gov ↗
N/DDiabetes Mellitus Tipo 2🇧🇷 1 site in Brazil

Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor

Glucotrack

📍 São Paulo👥 10 participants📅 Completion: 2025-02
View details →Refer patient →ClinicalTrials.gov ↗
N/DObesidade🇧🇷 1 site in Brazil

Endoscopic Treatment of Overweight and Mild Obesity with ORBERA365

Kaiser Clinic and Hospital

📍 Santo André👥 30 participants📅 Completion: 2026-02
View details →Refer patient →ClinicalTrials.gov ↗
N/DSobrepeso e Obesidade🇧🇷 1 site in Brazil

Acute Effects of Isoenergetic HIIE Vs. MICE on Key Parameters of Fat Mass Loss in Young Females with Overweight or Obesity

Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques

📍 São Paulo👥 15 participants📅 Completion: 2025-12
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Retocolite UlcerativaSobrepeso e Obesidade🇧🇷 15 sites in Brazil

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Eli Lilly and Company

📍 Aracaju, Brasília, Campinas, Caxias do Sul, Curitiba, Juiz de Fora, Porto Alegre, Ribeirão Preto, Salvador, Santo André, São Paulo, Vitória, Votuporanga👥 350 participants📅 Completion: 2028-04
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Doença de CrohnSobrepeso e Obesidade🇧🇷 15 sites in Brazil

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Eli Lilly and Company

📍 Aracaju, Brasília, Campinas, Caxias do Sul, Curitiba, Juiz de Fora, Porto Alegre, Ribeirão Preto, Salvador, Santo André, São Paulo, Vitória, Votuporanga👥 290 participants📅 Completion: 2028-05
View details →Refer patient →ClinicalTrials.gov ↗
N/DDiabetes Mellitus Tipo 2Resistência à InsulinaInflamação Crônica🇧🇷 1 site in Brazil

Therapeutic Strategies for Type 2 Diabetes Based on Lifestyle Changes: Plant-based Diet and Physical Exercise

Maria Elizabeth Rossi da Silva

📍 São Paulo👥 60 participants📅 Completion: 2026-12
View details →Refer patient →ClinicalTrials.gov ↗
N/DObesidade🇧🇷 1 site in Brazil

Systemic Vibratory Therapy and Osteopathic Manipulative Treatment in Individuals With Obesity

Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas

📍 Rio de Janeiro👥 90 participants📅 Completion: 2030-05
View details →Refer patient →ClinicalTrials.gov ↗
N/DSíndrome MetabólicaObesidadePolimorfismos Genéticos🇧🇷 1 site in Brazil

Impact of Genetic Polymorphisms And DASH Diet On Weight Loss Progression In Climacteric Women With Metabolic Syndrome

Nutrindo Ideais Research Center

📍 Rio de Janeiro👥 30 participants📅 Completion: 2025-10
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Doença Cardiovascular AteroscleróticaSobrepeso e Obesidade🇧🇷 36 sites in Brazil

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Amgen

📍 Fortaleza, Vitória, Salvador, Brasília, Goiânia, Campo Grande, Belo Horizonte, Uberlândia, Curitiba, Belém, Recife, Natal, Porto Alegre, Aracaju, Campinas, Marília, Santo André, São Bernardo do Campo, São José do Rio Preto, São José dos Campos, São Paulo, Tatuí, Votuporanga, Rio de Janeiro👥 12800 participants📅 Completion: 2030-09
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Insuficiência Cardíaca com Fração de Ejeção PreservadaInsuficiência Cardíaca com Fração de Ejeção Levemente ReduzidaObesidade🇧🇷 18 sites in Brazil

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Amgen

📍 Vitória, Goiânia, Belo Horizonte, Curitiba, Porto Alegre, Aracaju, Campinas, Marília, Ribeirão Preto, Santo André, São José do Rio Preto, São Paulo, Tatuí, Rio de Janeiro👥 5056 participants📅 Completion: 2030-09
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Diabetes Mellitus Tipo 2HipertensãoDoenças Cardiovasculares🇧🇷 23 sites in Brazil

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Boehringer Ingelheim

📍 Aracaju - SE, Belo Horizonte, Blumenau, Brasília, Campinas, Curitiba, Fortaleza, Goiânia, Joinville, Maceió, Manaus, Natal, Porto Alegre, Ribeirão Preto, Rio de Janeiro, Santa Cecília, São José do Rio Preto, São Paulo👥 11800 participants📅 Completion: 2029-12
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Apneia Obstrutiva do SonoObesidade🇧🇷 1 site in Brazil

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

Amgen

📍 Porto Alegre👥 250 participants📅 Completion: 2028-09
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3ObesidadeSobrepeso🇧🇷 13 sites in Brazil

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Eli Lilly and Company

📍 Brasília, Campinas, Fortaleza, Marília, Porto Alegre, Rio de Janeiro, São Paulo, Vitória, Votuporanga👥 1980 participants📅 Completion: 2030-07
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Osteoartrite de JoelhoSobrepeso e Obesidade🇧🇷 6 sites in Brazil

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Eli Lilly and Company

📍 Campinas, Rio de Janeiro, São Paulo👥 900 participants📅 Completion: 2028-05
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3Apneia Obstrutiva do SonoSobrepeso e Obesidade🇧🇷 10 sites in Brazil

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Eli Lilly and Company

📍 Campinas, Marília, Porto Alegre, Recife, Rio de Janeiro, Santo André, São Paulo👥 800 participants📅 Completion: 2028-04
View details →Refer patient →ClinicalTrials.gov ↗
Fase 3ObesidadeSobrepeso🇧🇷 7 sites in Brazil

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Eli Lilly and Company

📍 Curitiba, Fortaleza, São Paulo, Vitória, Votuporanga👥 900 participants📅 Completion: 2028-07
View details →Refer patient →ClinicalTrials.gov ↗
N/DDiabetes Mellitus Tipo 2PeriodontiteHalitose🇧🇷 1 site in Brazil

Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabetes Mellitus

University of Sao Paulo

📍 Bauru👥 32 participants📅 Completion: 2027-02
View details →Refer patient →ClinicalTrials.gov ↗
N/DSobrepeso e ObesidadeTranstornos AlimentaresPerturbação da Imagem Corporal🇧🇷 1 site in Brazil

Lifestyle Intervention for Obesity and Eating Disorder Prevention in Transgender Adolescents

University of Sao Paulo

📍 São Paulo👥 24 participants📅 Completion: 2026-12
View details →Refer patient →ClinicalTrials.gov ↗
N/DDiabetes Mellitus Tipo 2🇧🇷 1 site in Brazil

Autologous SVF Therapy for Type 2 Diabetes

Kaiser Clinic and Hospital

📍 São Jose Do Rio Preto👥 10 participants📅 Completion: 2026-12
View details →Refer patient →ClinicalTrials.gov ↗

Questions or requests?

Data deletion (LGPD/GDPR), partnerships, referrals, or any other matter.

Contact us →